Revagenix Inc.

San Mateo, CA

UEI
D98QFZUPFXJ9
CAGE
8B1Y9
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1729 Dolan Ave, San Mateo, CA 94401, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $14,231,864
FY2025 $670,845
FY2024 $17,912,826
FY2023 $5,121,040

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Health and Human Services $14,231,864

Contract awards

Quick answers

Is Revagenix Inc. registered in SAM.gov?

Yes. Revagenix Inc.'s SAM.gov registration is active through January 28, 2027.

What is Revagenix Inc.'s CAGE code?

Revagenix Inc.'s CAGE code is 8B1Y9, and its Unique Entity ID (UEI) is D98QFZUPFXJ9.

How much has Revagenix Inc. received in federal contracts?

Federal contracts obligated $670,845 to Revagenix Inc. in fiscal year 2025 and $37,936,575 in fiscal years 2023 through 2027.

What is Revagenix Inc.'s most recent federal award?

Revagenix Inc.'s most recent federal contract award is A novel lpxc inhibitor with pan-resistant pseudomonas and burkholderia activity (75N93022C00061), from National Institute of Allergy and Infectious Diseases (NIH), on September 22, 2022.

On GovTribe

See Revagenix Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe